OPTIKIRA

optikira-logo

OptiKira develops novel therapeutics intended to prevent cell death. It targets UPR and regulates its activity to prevent cell degeneration in idiopathic pulmonary fibrosis, nonalcoholic steatohepatitis, diabetes, cancer,, and various neurodegenerative diseases, enabling medical practitioners to treat Retinitis pigmentosa, amyotrophic lateral sclerosis, and other chronic diseases. OptiKira was founded in 2014 and is headquartered in Cleveland, Ohio.

#SimilarOrganizations #People #Website #More

OPTIKIRA

Industry:
Eyewear Health Care Medical Therapeutics

Founded:
2014-01-01

Address:
Cleveland, Ohio, United States

Country:
United States

Website Url:
http://www.optikira.com

Total Employee:
1+

Status:
Active

Contact:
(216)455-3216

Email Addresses:
[email protected]

Total Funding:
8.25 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Content Delivery Network Global Site Tag Euro Typekit Squarespace Squarespace Add To Cart


Similar Organizations

avivomed-logo

Avivomed

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

elicio-therapeutics-logo

Elicio Therapeutics

Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.

enchroma-logo

Enchroma

EnChroma develops eyewear for color blind people to improve human color vision.

entrada-therapeutics-logo

Entrada Therapeutics

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

kaio-therapy-logo

Kaio Therapy

Kaio Therapy develops a novel hyperthermia system that delivers controlled heat at the cellular level within a tumor.

oncology-therapeutics-network-logo

Oncology Therapeutics Network

Oncology Therapeutics Network

rainier-therapeutics-logo

Rainier Therapeutics

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

symbiotix-biotherapies-logo

Symbiotix Biotherapies

Symbiotix Biotherapies is a provider of a novel class of molecular therapeutics intended to develop molecules.

theradaptive-logo

Theradaptive

Theradaptive develops targeted therapeutics using its proprietary THX1 platform

viking-therapeutics-logo

Viking Therapeutics

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

Current Employees Featured

bradley-backes_image

Bradley Backes
Bradley Backes Co-Founder @ OptiKira
Co-Founder
2014-12-01

dustin-maly_image

Dustin Maly
Dustin Maly Co-Founder @ OptiKira
Co-Founder

scott-oakes_image

Scott Oakes
Scott Oakes Scientific Founder and Consultant @ OptiKira
Scientific Founder and Consultant
2014-11-01

feroz-papa_image

Feroz Papa
Feroz Papa Co-Founder @ OptiKira
Co-Founder

tim-pelura_image

Tim Pelura
Tim Pelura President and CEO @ OptiKira
President and CEO
2018-09-01

gregory-harriman_image

Gregory Harriman
Gregory Harriman Chief Medical Officer @ OptiKira
Chief Medical Officer

Founder


bradley-backes_image

Bradley Backes

dustin-maly_image

Dustin Maly

feroz-papa_image

Feroz Papa

scott-oakes_image

Scott Oakes

Official Site Inspections

http://www.optikira.com

  • Host name: 104.21.5.201
  • IP address: 104.21.5.201
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "OptiKira" on Search Engine